EDITOR-Familial hypertrophic cardiomyopathy (FHC) is an autosomal dominant disease with a wide range of clinical features; a "benign" condition in some families, it can cause a high incidence of sudden death in others. FHC is caused by mutations in at least nine genes encoding sarcomeric proteins. 1 The gene most commonly implicated in causing FHC is that encoding the -MHC protein. Over 60 missense mutations have been described in the -MHC gene. 1 The mutations identified cluster in exons 3-27 of this 40 exon gene; these encode the functionally important ATP, actin, essential and regulatory light chain binding sites. Based on analysis of clinical features in genotyped families (grouped by mutation), broad genotype-phenotype correlations have been proposed for individual mutations. Such analyses have shown that certain mutations of -MHC, for example Arg403Gln and Arg453Cys, produce a "malignant" phenotype associated with a high incidence of sudden death. 2 Others, such as Val606Met 2 and Leu908Val, 3 tend to behave in a "benign" fashion. However, a minority of families harbouring previously reported "benign" mutations show a greater than expected incidence of adverse events. 3 4 Classical genetic studies in model organisms have shown that "second hits" in a single gene can modify an abnormal phenotype. 5 Double mutations in cis, that is, in the same copy of a gene, have been postulated as a possible mechanism accounting for discrepancies in genotype-phenotype studies. For example, double mutations have been described in the enzyme cystathione beta-synthase causing particularly severe homocystinuria. 6 It is also possible that double mutations of disease genes may not be as rare as one might expect. A comprehensive mutation screen of 44 patients with cystic fibrosis found four had inherited one double mutant allele. 7 All evidence points to mutated -MHC genes acting in a dominant negative fashion, that is, the "poison polypeptide" hypothesis. 8 9 This model easily accommodates double mutations as phenotypic modifiers in FHC, with the "second hit" either further compromising, or improving, the function of the mutant protein within the sarcomere.
Mutation detection in FHC is complicated by its molecular heterogeneity. Mutations can be found eYciently, however, using a combination of linkage analysis where possible and TMHA. We have recently begun a comprehensive mutation screen of -MHC to investigate inconsistencies in genotype-phenotype correlation.
Methods and results
Family members were ascertained through our clinical practice and evaluated by physical examination, ECG, and echocardiography, allowing the diagnosis of familial hypertrophic cardiomyopathy (MIM 192600) to be made in those aVected. All participants gave informed consent and local ethical committee approval was granted. Findings in members of family A at presentation are shown in table 1 and fig 1. II.9 declined participation, but is an obligate carrier based on his position in the pedigree.
There were three instances of sudden death. III.5 died aged 17 years and II.6 died aged 30 years. I.1 died suddenly aged 60 years with clear necropsy evidence of FHC (heart weight 540 g) but also pathological features of coronary artery disease. DNA was extracted from peripheral lymphocytes and linkage analysis was performed using flanking microsatellite markers. 10 Analyses in family A were consistent with a -MHC causative mutation (fig 1) . Intronic primers were designed flanking each exon from 3-27 of -MHC. DNA from two aVected subjects (II.2, II.7) was amplified using high fidelity polymerases and "touchdown" PCR. 11 Mobile phase gradients and melting temperatures for TMHA of each amplimer were calculated using the Wavemaker™ software package. Analysis of the PCR products using a DHPLC apparatus (Transgenomic Wave™) showed heteroduplex formation, indicative of heterozygous variants, in exon 3 in one subject and in exons 16 and 20 in both. 12 The exon 3 variant is a common polymorphism that we have seen in approximately 20% of normal chromosomes. Sequence analysis of this variant (T275C) did not predict an amino acid change. Haplotype analysis indicates that the two other variants are present on the same disease associated parental chromosome (fig 1) . The presence of both variants in all available aVected subjects was confirmed by DHPLC.
Sequencing of these PCR products on an ABI377 showed a G>A transition resulting in the previously described Val606Met mutation in exon 16 and a C>T transition resulting in an Ala728Val mutation in exon 20 ( fig 2) . The Ala728Val introduces an MscI site. Restriction enzyme analysis of 200 control chromosomes excluded the possibility that the mutation was a common polymorphism (data not shown). The alanine residue at this position has been conserved in diverse myosin isoforms from Drosophila to man and lies close to the essential light chain interface. Therefore, we predict that both the Val606Met and Ala728Val mutations are pathogenic.
Discussion
Previous studies in four families suggest that Val606Met is a benign mutation. 2 13 This clinical impression was supported by recent in vitro analyses. 14 The disease in family A, however, has produced two instances of early sudden death (fig 1, II.6 and III.5) and contributed to the death of a further person (I.1) in eight known aVected subjects. In addition, two aVected subjects (II.2, III.3) presented with symptoms or signs in childhood. We propose that this adverse natural history reflects the Ala728Val mutation acting in concert with the Val606Met mutation. Because the mutations are expected to aVect both actin and myosin light chain interactions, they are likely to have a cumulative detrimental eVect on myosin function. If, in screening this gene, we had discontinued our analysis on discovery of the Val606Met substitution, used low sensitivity techniques, or typed only for known mutations, 3 the Ala728Val mutation would have remained undetected and the severe phenotype would have been wrongly attributed to the Val606Met mutation. Until the frequency of double mutations in FHC is known, great care is needed in establishing genotype-phenotype correlations and in genetic analysis based on typing known mutations.
Examples of two mutations within an FHC family have been described, but these have not been found through further analysis of the same allele. The second mutation in these examples has been either non-pathogenic, 8 situated in a diVerent FHC disease gene, that is, leading to double heterozygosity, 15 or identical by descent in consanguineous families. 16 Although such double heterozygous and autozygous subjects are of interest, the two mutations are unlikely to cosegregate in many members of a family. Therefore, these phenomena may contribute to discordant phenotypes in particular subjects with FHC, but will not have a systematic impact on genotype-phenotype correlation. A similar argument pertains to the much discussed "genetic background" eVect as an explanation for families who have discordant phenotypes. A constellation of unlinked genes aVecting the phenotype of a dominant disorder are unlikely to cosegregate with the disease causing allele for more than one or two meioses. Only if such unlinked disease modifiers are much more common in one population than another, and hence are continually reintroduced into certain family "gene pools", could they have a consistent eVect on disease phenotype. In contrast, two (or more) tightly linked mutations will continue to be inherited together and so will confound genotypephenotype correlations based on either mutation alone, even in very large families.
Analysis of FHC families who do not match the expected phenotype of their known mutation could provide further examples of "double mutations" having a deleterious, or even conceivably a beneficial eVect. Until such studies are performed it is impossible to state how common disease modifiers in cis will be. However, it is notable that the contractile protein genes are large targets for mutation, with FHC causing mutations arising over extensive genomic regions; thus, double mutations may be relatively frequent. Our data do not indicate how this compound allele evolved. Empirically, it is perhaps most likely that the mutations arose independently; indeed, examples of the Val606Met mutation have arisen before as independent events, 17 and such relatively mild alleles would be more likely to persist longer in the population, increasing the likelihood of a "second hit" in that gene.
We conclude that genotype-phenotype correlations in FHC can be confounded by the presence of more than one mutation in a single copy of a disease gene. Genotype-phenotype correlations have become increasingly important in the study of disease. In addition to helping formulate a prognosis for the individual patient, they allow us to define prognostic groups which may be used, for example, to assess treatment. Analysis of genotyped patient groups allows us to understand better the functional impact of the mutated protein and gain an understanding of the pathogenic mechanisms of the disease. This study illustrates how such analyses could be misleading if a comprehensive analysis of the gene in question has not been undertaken.
We thank family members for participation and the British Heart Foundation for supporting the work. Catherine J Baty is a recipient of a Burroughs Wellcome Fund Hitchings-Elion Fellowship. Identification of a large rearrangement of the BRCA1 gene using colour bar code on combed DNA in an American breast/ovarian cancer family previously studied by direct sequencing Sophie Gad, Maren T Scheuner, Sabine Pages-Berhouet, Virginie Caux-Moncoutier, Aaron Bensimon, Alain Aurias, Mark Pinto, Dominique Stoppa-Lyonnet EDITOR-Linkage data suggest that BRCA1 and BRCA2 gene alterations account for the majority of hereditary breast/ovarian cancer cases. 1 Though comprehensive screening of the BRCA1 gene has been attempted on a number of occasions, only two thirds of expected mutations have been detected so far. [1] [2] [3] Most eVorts have relied on standard PCR techniques, including direct sequencing, single strand conformation polymorphism (SSCP) analysis, heteroduplex analysis (HDA), denaturing gradient gel electrophoresis (DGGE), and protein truncation testing (PTT), with a focus on point and small mutations. 2 The relatively low rate of detection of BRCA1 gene mutations may be because of the existence of large rearrangements, which are not detected by such approaches. Supporting this hypothesis, a number of large rearrangements, ranging from 0.5 to 23.8 kb and spanning the entire BRCA1 gene, have recently been detected by Southern blotting, analysis of BRCA1 lymphocyte transcripts, and long range PCR. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] In most cases, the characterised rearrangements are the result of unequal recombination events between Alu sequences, which cover 41.5% of BRCA1 introns. 15 Here we report the identification, using colour bar coding on combed DNA, of a previously undescribed large rearrangement of the BRCA1 gene in an American breast/ovarian cancer family with ancestors from France and Germany (fig 1) .
Material and methods
The index case was diagnosed with breast cancer at the age of 30 and ovarian cancer at the age of 49. She had one sister with breast cancer diagnosed at the age of 35, another sister with ovarian cancer diagnosed at the age of 35, and a paternal grandmother with breast cancer diagnosed at the age of 41. The index case was referred to Cedars-Sinai Medical Center (Los Angeles, USA) for a genetic consultation. She elected to participate in BRCA gene testing, as she hoped to characterise her apparent genetic susceptibility so that her daughter could know her own status with greater certainty. No BRCA1 or BRCA2 gene mutation was identified by direct DNA sequencing (BRACAnalysis TM , Myriad Genetic Laboratories Inc, Salt Lake City, USA). Because the a priori likelihood of carrying a BRCA gene mutation was high, the case was referred to our laboratory to search for large rearrangements in the BRCA1 gene (family quoted IC2361).
The strategy for the detection of large rearrangements developed in our laboratory is based on a full four colour bar code of the BRCA1 region on combed DNA. 16 Combing relies on homogeneous stretching of DNA molecules at a constant rate of 2 kb/µm. 17 Fluorescence in situ hybridisation (FISH) is then performed on combed DNA. 18 The probes used include a PAC covering the whole BRCA1 region and long range (LR) PCR products (6.5 to 10 kb long) covering a number of exons, therefore bar coding the PAC. We have optimised the BRCA1 bar code reported by Gad et al 16 by adding new LR products to allow for the detection of rearrangements as small as 2 kb. Finally, in addition to the PAC, a complex bar code of the BRCA1 region was designed with seven probes (fig 2) . This approach allows for a panoramic view of the BRCA1 gene and its flanking regions.
Germline DNA was extracted from a lymphoblastoid cell line, with a step in agarose blocks in order to preserve its integrity. After combing of the DNA on silanised surfaces 17 18 and FISH with the set of probes, microscope screening was then performed.
Results
With a few fields of microscopic view, a number of full signals without LR13-15 probes were 2B) . In order to characterise the deleted exons better, the bar code was adapted by using two additional probes, covering exons 12-13 and exons 15-18. Taking the sizes of BRCA1 exons and introns into account, 15 as shown in fig 2C , the deleted region was expected to comprise exons 13, 14, and 15.
To characterise the mutant mRNA, we performed RT-PCR using primers located at the 3' end of exon 11 and in exon 16. A normal product was detected both in control and patient DNA corresponding to the 824 bp expected product ( fig 3A) . In the patient, a mutant product was also observed, corresponding to the 334 bp product expected in the absence of exons 13 to 15 ( fig 3A) . Sequencing of this shorter product showed that exons 12 and 16 were adjacent (fig 3B) , leading to a premature stop codon at position 1437 and truncation of the BRCA1 protein. Thus, the deletion of exons 13 to 15 appears to be the origin of the cancer predisposition in this family.
In order to define the boundaries of the deletion, long range PCR was performed on genomic DNA using primers located in exons 12 and 16. From the patient's DNA, an abnormal product was observed at 8.5 kb, whereas the 20.2 kb expected product was not observed in control DNA ( fig 3A) . The 8.5 kb product was gel extracted. Its restriction map was determined (data not shown) and compared to the restriction map of the normal region of exons 12 and 16 (accession number Genbank L78833 15 ). From this comparison and by taking the location of the Alu sequences in this region into account, we hypothesised that a recombination event had occurred between two Alu sequences, in the 3' end of intron 12 and the 5' end of intron 15, respectively. Primers were designed to amplify a DNA fragment comprising the putative breakpoints. From the patient's DNA, a 550 bp fragment was obtained, gel extracted, and sequenced ( fig  3A) . It showed that unequal recombination had occurred between an Alu Sx in intron 12 and an Alu Sp in intron 15. These two Alu sequences share 86% homology (data not shown). Recombination breakpoints were located between nucleotides 44 377 and 44 397 in Alu Sx and between nucleotides 55 980 and 56 000 in Alu Sp (accession number Genbank L78833 15 ), resulting in a 11 604 bp deletion ( fig 3C) .
In order to examine the frequency of this rearrangement among breast/ovarian cancer families, we screened a series of 90 women aVected with breast or ovarian cancer and ascertained at the cancer genetics clinic of the Institut Curie (Paris, France) according to family criteria previously reported. 3 Most of patients had French ancestors. These women, screened negative for BRCA1 and BRCA2 point mutations, were then tested for the presence of the 550 bp PCR product by using (2) shows that the deletion comprises only exons 13 to 15. primers "Alu intron 12 forward" and "Alu intron 15 reverse". No 550 bp fragment was observed, suggesting that this rearrangement is not frequent in the population studied (data not shown).
Discussion
Our report of a previously undescribed 11.6 kb deletion encompassing exons 13 to 15 of the BRCA1 gene illustrates the diversity of large rearrangements and their contribution to the molecular pathology of the BRCA1 gene. Few series of breast/ovarian cancer families have been systematically screened for large rearrangements of the BRCA1 gene. The reported frequencies of BRCA1 rearrangements range between 12% and 36%. 4 6 7 14 Even with a conservative estimate of 10%, it would be advisable to include a search for large rearrangements in BRCA1 when analysing high risk breast/ ovarian cancer families. The family reported here serves as a prime example of a case in which additional testing was warranted in the absence of a detectable point mutation with standard PCR methods. The prior probability of the index case being a BRCA1/2 mutation carrier has been estimated at 95%. This value was obtained by using the MLINK program of the LINKAGE package, with the parameters of the Claus segregation model modified by Easton and the estimated contributions of BRCA1 and BRCA2 mutations to breast/ovarian cancer predisposition. 1 19-21 In the absence of an identifiable mutation, closely related family members would have to be considered to be at high risk and would have to make decisions regarding cancer prevention on the basis of empirical data. With the identification of the familial BRCA1 deletion, at risk family members can now consider testing for the identified familial mutation and can learn their mutation status with certainty.
The broad diversity of rearrangements, ranging from 0.5 to 23.8 kb and spread over the 81 kb of the BRCA1 region, requires methods that allow for complete analysis of the gene. In this respect, colour bar coding on combed DNA appears useful. It allows for a panoramic view of the BRCA1 region and for the detection of a rearrangement of about 6 kb (the size of a probe deleted or duplicated) at a glance. In addition, deletions and duplications as small as 2 kb can be detected with measurement of the probe signals. 16 Finally, more complex rearrangements involving inversions can also be detected. We think that software allowing for the automatic capture and analysis of signals would streamline the approach and, therefore, favour the use of colour bar coding on combed DNA. Searching for large gene rearrangements is a recurrent challenge for molecular geneticists. In addition to Southern blotting, other promising PCR based methods have recently been reported, including a long range PCR strategy and quantitative PCR. 11 22-24 Haploid conversion of human lymphocytes via a cell fusion strategy may be another alternative to these methods, as it allows for suppression of the normal allele, facilitating the detection of large rearrangements by standard PCR. 25 Comparative analysis of the diVerent methods listed above, taking both sensitivity and cost into consideration, are now needed to improve genetic testing for breast and ovarian cancer predisposition.
We are indebted to the family for participating in this study. This work was supported by the Institut Curie "Programme Incitatif Autosomal dominant congenital cataract (ADCC) is a clinically and genetically heterogeneous group of disorders that cause blindness. More than 13 independent loci have been mapped, and 10 diVerent genes identified so far. Five of them are crystallin genes that are categorised into the , , , µ, and subgroups. The crystallins constitute the main lens proteins, whereby -crystallin B2 is the only abundant protein in the adult lens fibre in man. 1 2 Causative mutations have been recognised in the -crystallin A gene (zonular central nuclear cataract), 3 the -crystallin A3/A1 gene (zonular cataracts with sutural opacities), 4 the -crystallin C gene (Coppock-like cataract), 5 and the -crystallin D gene (progressive juvenile onset punctate cataract). 6 These and all other ADCC mutations identified so far are private mutations, with one exception. Litt et al 7 described a nonsense mutation, Q155X, in the -crystallin B2 gene leading to cerulean cataract. Exactly the same mutation was identified by Gill et al 8 in familial Coppock-like cataract. Here, we report the identical mutation in a large Indian family exhibiting sutural cataract with punctate and cerulean opacities. In addition, we present evidence that this mutation in the -crystallin B2 gene is an independent event and most likely the result of gene conversion.
Identification and characterisation of the mutation
After obtaining informed consent, we performed linkage analysis in an Indian five generation family with 33 aVected members, based on semi-automated genotyping with microsatellite markers from the Généthon linkage map; 48 members of this family, 25 of them aVected, were selected for mapping ( fig  1A) . Assuming autosomal dominant inheritance with full penetrance and equal allele frequencies for each marker and using the LINKAGE program package, we calculated two point lod scores. After having excluded the autosomal dominant cataract loci on chromosomes 1, 2, 12, 13, 14, 16, 17, and 19, we detected linkage in our family to marker D22S315, with a lod score of Zmax = +8.500 at max = 0.05. This region on chromosome 22 harbours four -crystallin genes, CRYBA4, CRYBB1, CRYBB2, CRYBB3, and the pseudogene CRYBP1. 9 We amplified the translated exons 2-6 of the CRYBB2 gene by PCR as described previously. 7 In addition, we designed primer sets for maximum discrimination between gene and pseudogene sequences: CRYBLg (5'-TGACCTTGTAGCTGGGCTTG-3'), CRYBLpsg (5'-TGACTTTGCAGCCAGGCTT G-3'), 596rg (5'-CACTGCATGTCGCGGAT ACG-3'), 596rpsg (5'-CCCTGCATGTCGT GGATGCA-3'). PCR products were purified with a Qiaquick PCR purification kit (Qiagen, Hilden, Germany) and sequenced directly using the Big-Dye-Terminator Cycle Sequencing Kit (PE Biosystems, Weiterstadt, Germany). Sequencing reactions were purified with a Dye-Ex Kit (Qiagen, Hilden, Germany) and run and analysed on ABI 310 and 377 sequencers (PE Biosystems, Weiterstadt, Germany).
Sequencing of exon 6 showed a C→T mutation at nucleotide position 475 (Q155X). This stop mutation truncates the protein by 51 residues and has previously been described. the mutation Q155X creates a BfaI restriction enzyme site and the variant 483C→T destroys an MspI site, PCR products were BfaI and MspI (New England Biolabs, Frankfurt, Germany) digested and separated on agarose gels. The results showed complete cosegregation of mutation, variant, and disease in our family ( fig  1B, C) . Q155X and 483C→T were not found on 180 chromosomes of normal Indian subjects, excluding either from being a frequent polymorphism.
To address the question whether the mutations in our Indian family and the American family of Litt et al 7 are derived from a single mutational event or represent recurrent mutations, we established the haplotypes at the CRYBB2 locus, based on closely linked microsatellite markers. Their order and genetic distance is TOP1P2 -3 cM -CRYBB2 -1 cM -D22S258. 10 The haplotypes were 133-173-180 in the Indian and 165-171-180 in the American family, indicating that the mutation Q155X arose independently on chromosomes with diVerent haplotypes. This is confirmed by the "normal" cytosine at position 483 in the patients of Litt et al 7 and Gill et al, 8 as can be seen from the published sequences.
Gene conversion
Altogether these data point to a hot spot of mutation in exon 6 of the CRYBB2 gene. Since the two sequence alterations in the Indian family, Q155X and 483C→T, are both cytosine to thymidine mutations, cytosine deamination as the mutational mechanism cannot be ruled out a priori. However, if one takes into account that the region harbours four closely related -crystallin genes and a pseudogene (fig 2A) , two other mutational mechanisms need to be considered, unequal crossing over and gene conversion.
By alignment of the DNA sequences of the -crystallin genes, it became clear that CRYBB2 is much more similar to the closely linked pseudogene CRYBP1 than to the other -crystallin genes ( fig 2B) . This finding suggests a recent duplication of a common precursor gene where one of the duplicated genes was maintained (CRYBB2) and the other one accumulated point mutations, turning it into a pseudogene (CRYBP1). The physical distance of 228 kb between CRYBB2 exon 6 and the homologous sequence in the pseudogene CRYBP1 (fig 2A) is compatible with both unequal crossing over and gene conversion. To our surprise, the alignment of the crystallin gene sequences showed that the alterations Q155X and 483C→T in the CRYBB2 mutant are identical to the "normal" sequence in the pseudogene ( fig 2B) . Thus, the two alterations, Q155X and 483C→T, define a fragment of at least 9 bp of pseudogene-like sequence in the CRYBB2 gene. These 9 bp are flanked upstream by 28 bp and downstream by 67 bp where the gene and pseudogene are identical ( fig 2B) . At the nucleotides 29 bp upstream and 68 bp downstream that diVer between gene and pseudogene, the patients showed homozygosity for the CRYBB2 sequence. Therefore, the mutant allele carries more than 9 bp but less than 104 bp of pseudogene-like sequence ( fig 2B) .
In principle, recombinational events resulting from unequal crossing over or gene conver- Thus, the most likely explanation is that gene conversion between CRYBB2 exon 6 and its homologous CRYBP1 sequence led to the pseudogene-like alteration in the CRYBB2 gene. This assumption is in agreement with the shortness (<104 bp) of the replaced fragment. It was estimated that gene conversions between human -globin genes are less than 300 bp in length 11 and between human -globin genes less than 451 bp. 12 Our assumption of gene conversion is also supported by the presence of sequences that were described to promote gene conversion. Gene conversion is considered to be initiated at or near special sites. 13 The critical region in our patients is flanked by the chromosomal junction sequence ATGCAG 14 with one mismatch and also bears a hypervariable minisatellite GGGCAGGA(A/G)G 15 with one mismatch ( fig 2B) . Putative gene conversion between highly homologous genes, as in this family, was previously described at several other loci, for example, the -globin genes, 16 the oxytocin vasopressin genes, 17 or the steroid 21-hydroxylase gene and its pseudogene. 18 Summarising all our data, we conclude that gene conversion between CRYBB2 and its pseudogene CRYBP1 is the most likely explanation for this mutation in exon 6 of the CRYBB2 gene.
Phenotypic variation and modifiers
There are now three families described that carry the CRYBB2 Q155X mutation. However, each of these shows a diVerent phenotype. The clinical diagnosis in our Indian family is sutural cataract with punctate and cerulean opacities. The slit lamp examination ( fig 3) showed prominent, dense, white opacification around the anterior and posterior Y sutures. The posterior Y sutures and the posterior pole of the lens were more severely aVected than the anterior pole. It also showed greyish and bluish, sharply defined, elongated, spindle shaped, and oval punctate and cerulean opacities of various sizes arranged in lamellar form. The spots were bigger and more concentrated towards the peripheral layers. These did not delineate the embryonal or fetal nucleus. No pulverulent disc-like opacity was observed in the nuclear region. The sutural opacities appeared denser and whiter compared to the punctate and cerulean spots and were also more elongated and larger in size. Phenotypic variation with respect to the size and density of the sutural opacities as well as the number and position of punctate and cerulean spots was observed among the aVected members. Some subjects showed severely affected sutures with dense white opacifications spreading along the secondary divisions of the Y sutures. In some aVected subjects the spots were present only as a single layer in the cortex while in the others the spots occurred in concentric layers involving the whole cortex.
The phenotype of this Indian family, sutural cataract with punctate and cerulean opacities, diVers from all other reported forms of cataract. The American family of Litt et al 7 has pure cerulean cataract, and the Swiss family of Gill et al 8 shows Coppock-like cataract. The phenotype of our family overlaps with the American family, both showing cerulean opacities. However, the sutural cataract and the punctate opacities in our phenotype have not been reported in the American or Swiss families. Moreover, the prominent pulverulent central disc-like opacity involving the embryonal and fetal nucleus seen in the Swiss family is not present in the American or this Indian family. There is not even an overlap between the phenotype of the Swiss family and the other two families.
Hence, we conclude that the Q155X mutation causes cataract formation but the distinct type of cataract depends on modifying genetic and epistatic factors. The influence of modifiers would make it impossible to infer the mutant gene from the cataract phenotype. Consequently, ADCC patients would need to be analysed for much more than only one ADCC gene.
Cis acting major modifiers could explain the considerable phenotypic variability between families. Minor modifying factors, acting in trans, could cause the phenotypic diVerences within families. The minor modifier of our family is obviously not linked to the Q155X mutation, since there is considerable clinical variability within our patients who share an identical haplotype. Interestingly, this excludes three further crystallin genes, CRYBA4, CRYBB1, and CRYBB3 (fig 2A) , from being the minor modifier. On the other hand, exactly these crystallin genes are candidates for being the major modifier. 1 At least 30 DFNB loci have been mapped in the past few years by genetic linkage studies, but the causative gene has been identified for only eight of these loci [2] [3] [4] (Hereditary Hearing Loss Homepage, http:// www.uia.ac.be/dnalab/ hhh).
Two of the previously reported loci for non-syndromic recessive deafness are DFNB8 and DFNB10, both located on chromosome 21q22.3 (MIM 601072 and 605316). The DFNB8 locus was originally identified in a large consanguineous Pakistani family, segregating childhood onset deafness, 5 while DFNB10 was identified in a large consanguineous Palestinian family, in which deafness was congenital. 6 Recently, the TMPRSS3 gene was shown to be mutated in aVected subjects of both families.
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TMPRSS3 belongs to a family of transmembrane serine proteases, also including TMPRSS1, 8 TMPRSS2, 9 and TMPRSS4. 10 The TMPRSS3 gene extends over 24 kb and comprises 13 exons. It has four alternative transcripts (TMPRSS3 a, b, c, and d), encoding putative peptides of 454, 327, 327, and 344 amino acids, respectively. 7 TMPRSS3a, which contains all 13 exons, is the most abundant transcript and its expression could be detected in various tissues, including fetal cochlea. 7 In addition to the serine protease and the transmembrane domains, TMPRSS3 also encodes low density lipoprotein receptor class A (LDLRA) and scavenger receptor cysteine rich (SRCR) domains, which are potentially involved in binding with extracellular molecules and/or the cell surface. 
Material and methods
To identify DFNB8/B10 linked families, we analysed a total of 159 consanguineous Pakistani families that segregate profound congenital deafness and are either large enough to support statistically significant linkage or have at least three aVected subjects. Families were ascertained in schools for the deaf in Punjab and Karachi. IRB approval (OH93-DC-016) and informed consent were obtained for all participating family members. Genomic DNA was extracted from venous blood samples according to a standard protocol. 11 Linkage to known recessive deafness loci (DFNBs) and refinement of the DFNB8/B10 region in linked families was performed on an ABI-377 sequencer (PE Applied Biosystems) using marker information provided by the Hereditary Hearing Loss Homepage and by Berry et al. 12 Linkage analysis was conducted with the FASTLINK version of the LINKAGE program package. 13 14 Five of the families showed potential linkage to the DFNB8/B10 locus on chromosome 21q22.3 ( fig 1) . Medical history and pure tone audiometry testing indicated that all five families segregate congenital, profound, non-syndromic sensorineural deafness.
Results and discussion
To detect mutations in the TMPRSS3 gene in DFNB8/B10 families, we determined the gene sequence in two aVected subjects from each family by PCR amplification from genomic DNA of the 13 exons, including intron-exon boundaries, and cycle sequencing of the PCR products using TMPRSS3 specific primers. Primer sequences and PCR conditions are summarised in purified with the QIAquick PCR purification kit (Qiagen). Sequence analysis using one of the amplification primers or an internal primer was performed with the Big Dye terminator cycle sequencing kit on an ABI-377 sequencer (PE Applied Biosystems). Novel TMPRSS3 mutations were identified in four of the families. The relevant TMPRSS3 exons in all available family members were then amplified by PCR and sequenced. This confirmed that in each family deaf subjects were homozygous for the TMPRSS3 mutation and obligate carrier parents were heterozygous. Family and mutation data, including population study results for each mutation, are summarised in table 2. Several single nucleotide polymorphisms (SNPs) were also identified in both coding and non-coding sequences of the TMPRSS3 gene (table 3) . Families PKSN37 and PKSR18b (fig 1A, B) were found to segregate the same TMPRSS3 missense mutation, C407R (table 2) . This mutation is a T to C transition at position 1420 (1219 from the first ATG) (GenBank accession number AB038157), located in exon 12, and leads to a cysteine to arginine substitution. C407 is located in the serine protease domain of TMPRSS3, only a few amino acids from the active site residue S401 within the substrate 2  GATGCACCTGATGCTACAAG  GGACAGTCAGTCACATTGGTC  286  55  12  3  GGACTGAACTAGAGAATGTGCC  GACAAAGCCATGAGCATGGC  510  55  4  AGGGGGACAGTTGTTAGTGTTGC  TACAGATGGGAAGGGTCAGGGTTG  261  60  12  5  TGTGGAGAAACCCCTGCCTATG  GATGTGAGGATGTAATCTGAGAGCG  323  55  9  6  GACTCGCACATCGGTTGAATG  ATACTCCCTCAGGTTCTCACACCC  387  55  12  7  GTGTGACCTCATCCTCATGG  CTCTGAGGGCAAGGAGATAG  293  60  9  8  TAGAGCTGCTGTGAGCTCTG  AGACTCCTCTCCAACTGTAC  438  55  10  9  GGACCACATCTTGCCTGATAACC  AAAGCACACAGCCCACGAAG  694  60  12  10  CTCCTGCTGTGAGCTGATCG  CGAGCAGCTGACATGCACTC  393  55  10  11  GTCTCAGCATGCGCCTTCTG  CCCACGCAGAGCCAGATCAC  407  60  12  TGGGTCATCCATTGGGACATC  TCTCTGTTTTCAGCACAAGCGTC  460  55  12  13  TACGGAAGTGACGGAACTGTCG  CTTGAAGGTTGTGCTGGAATCAG  442  60 *The number of Opti-Prime buVer (Stratagene) used for PCR amplification. Other reactions were performed with a standard PCR buVer (PE Applied Biosystems), with 1.5 mmol/l MgCl 2 . †Touchdown.
pocket, and thus may be important in substrate specificity. Although C407 is not highly conserved, three out of the other four known TMPRSS proteins (mouse and human TMPRSS2 and human TMPRSS1) have either a cysteine or a threonine at this position, both of which are polar, uncharged amino acids, while the mutation changes the amino acid at this position to the positively charged arginine. All aVected subjects were homozygous for the C407R mutation and obligate carriers were heterozygous ( fig 1A, B 1C) . This mutation is a C to T transition at position 526 (325 from the first ATG) (GenBank accession number AB038157), located in exon 5, and leads to an arginine to tryptophan substitution. Three out of the other four known TMPRSS proteins have either an arginine or the similar positively charged histidine at this position (mouse and human TMPRSS2 and human TMPRSS4). R109 is located within the SRCR domain of TMPRSS3. The SRCR is an adhesive extracellular domain (PROSITE Database of Protein Families and Domains, http:// www.expasy.ch/prosite, accession number PDOC00348), which is potentially involved in 15 The disease allele frequency was set at 0.00001 and four equally frequent alleles were assumed for any marker. The disease was coded as fully penetrant, genetically homogeneous, and recessive.
†The nucleotide changes follow the nomenclature rules of Dunnen and Antonarakis. 18 Nucleotide position relates to TMPRSS3 cDNA (GenBank accession number AB038157). ‡Pakistani controls were collected in Lahore, Pakistan. Muslim Indian controls were collected in northern India, near the Pakistani border. §Not tested. binding of TMPRSS3 with extracellular molecules and/or the cell surface. 7 All aVected subjects belonging to the main branch of the family were homozygous for the R109W mutation and obligate carriers were heterozygous ( fig 1C and  2B ). Yet, subject I.2, who is deaf, was found to be homozygous for the normal allele. This finding is not surprising, since our initial genotyping data indicated that I.2, who belongs to a remote branch of the family, has a diVerent haplotype at the DFNB8/B10 region than the haplotype shared by the other deaf subjects in the family ( fig 1C) . Thus, her deafness might be the result of a mutation in a diVerent gene or the result of non-genetic factors.
Family PKB16 ( fig 1D) was found to segregate a third missense mutation, C194F (table 2) . This mutation is a G to T transversion at position 782 (581 from the first ATG) (GenBank accession number AB038157), located in exon 7, which encodes part of the SRCR domain, and leads to the substitution of the cysteine at position 194, which is highly conserved among all TMPRSS proteins, to phenylalanine. All aVected subjects were homozygous for the C194F mutation and obligate carriers were heterozygous ( fig 1D and 2C) .
Family PKSR7 ( fig 1E) supports a simulated maximal lod score of 3.8 (FAST SLINK 15 ), and deaf subjects are homozygous for markers spanning the DFNB8/B10 region ( fig 1E) . The region of homozygosity is shared by all aVected subjects, but is more restricted in one of the sibships (fig 1E, II.9-13 ). However, none of the markers is fully informative, resulting in a maximal calculated lod score of 2.9. The disease allele frequency was set at 0.0011 (upper limit for recessive deafness based on estimates from the Indian population 16 ) and the disease was coded as fully penetrant and recessive with a 1/1000 phenocopy rate. Allele frequencies of 0.1 and 0.2 for each allele of markers 834A1.CA78 and 994G8.CA82, respectively, were assumed based on observations in the other analysed Pakistani DFNB8/ B10 families. The lod score was not significantly changed by omitting subjects II.9-13 (2.7), nor by increasing 834A1.CA78 and 994G8.CA82 allele frequencies to 0.4 each (2.3). Since linkage analysis for this family did not obtain a significant lod score, it is possible that deafness in family PKSR7 is not actually linked to the DFNB8/B10 locus, and the homozygosity observed in this region is incidental. However, it was previously estimated that 60% of all Pakistani marriages are consanguineous. 17 It is unknown whether I.15 is related to family PKSR7. Recalculation of the lod score under the assumption that I.14 and I.15 are first cousins resulted in a maximum two point lod score of 4.2. Thus, this family may have a mutation in a regulatory element of the TMPRSS3 gene, or alternatively it might carry a mutation in a diVerent gene located in the same region.
R109W and C194F were not found in any of the normal control Pakistani or Muslim Indian chromosomes tested, while the C407R mutation was found in 1 of 200 Muslim Indian control chromosomes. In addition, C407R was found in two of our DFNB8/B10 families. Taken together, these findings imply that the carrier frequency for C407R in the Muslim Indian-Pakistani population is higher than for the other TMPRSS3 mutations described in this manuscript. Moreover, finding of pathogenic TMPRSS3 mutations in four out of a total of 159 Pakistani families segregating profound congenital recessive deafness indicates that TMPRSS3 mutations contribute to approximately 2.5% of the recessively inherited deafness cases in the Pakistani population (95% confidence interval 0.7-6.3). This is a significant contribution, considering the high level of genetic heterogeneity of recessively inherited deafness in general, and in this population in particular.
To estimate the contribution of TMPRSS3 mutations to genetic deafness in North America, we sequenced all TMPRSS3 coding exons (exons 2-13) in a panel of 64 deaf North American subjects. DNA samples of North American deaf subjects were obtained from the National DNA Repository for Research on Deafness (NDRRD) based at the Virginia Commonwealth University. None of the subjects included in the screened panel had any obvious syndromic or environmental cause for their deafness based on their medical history. Subjects with identifiable mutations in GJB2 (Cx26) (based on complete sequencing of exon 2 of the GJB2 gene) or with known mitochondrial deafness related mutations were also excluded from this panel. The panel includes subjects from both multiplex (25) and simplex (38) families, with the following ethnic origins: 54 whites, two African-Americans, two Hispanic, three Asians, one Indian, and two of unknown origin. We identified several common SNPs in both coding and non-coding sequences of the TMPRSS3 gene (table 3) . Interestingly, no TMPRSS3 mutations were detected. Comparison of this finding to another deafness related gene, GJB2 (Cx26), which accounts for approximately 20% of nonsyndromic, recessive hearing loss, 4 indicates that TMPRSS3 is not a major contributor to genetic deafness in North America. Direct comparison between our findings in the North American panel and in the Pakistani population is diYcult, since some of the subjects included in the panel are sporadic cases. This is unlike the Pakistani families we analysed, which are all consanguineous families with multiple aVected subjects. Thus it is possible that some of the North American deaf analysed do not actually have a genetic cause for their deafness, while deafness in the Pakistani families is most probably genetic. The five TMPRSS3 deafness related mutations identified to date include missense (current report), splice site, and insertion mutations, 7 which aVect various domains of the TMPRSS3 protein (fig 3) . and a preferential association with this haplogroup has also been observed for the 11778G>A mutation. 4 The homoplasmic transition A to G at nt 4336 (4336A>G) in the mtDNA tRNA Gln gene has been found at low frequency in populations of European origin. This nucleotide connects the amino acid acceptor stem with the T C stem of tRNA Gln and is moderately conserved between species. 5 It is thought to entail an increased risk of Alzheimer's disease (AD) and Parkinson's disease (PD), 1 5-7 but its possible role in diseases manifesting in middle life has not been evaluated. We therefore set out to study the frequency of this mutation among middle aged patients with various clinical phenotypes and in healthy, age matched controls (group 1), and also in patients with late onset neurodegenerative diseases and elderly, cognitively normal controls (group 2). We determined the entire mtDNA sequence in 10 patients and three controls with 4336A>G by conformation sensitive gel electrophoresis (CSGE) and subsequent sequencing.
Material and methods
Group 1 contained 575 patients and 480 controls (table 1) . Patients with diabetes mellitus, epilepsy, sensorineural hearing loss, occipital stroke, ophthalmoplegia, intracranial calcification, white matter disease, ataxia, and migraine were ascertained as described previously.
8-11
The patients with diabetes mellitus, epilepsy, or sensorineural hearing loss had a family history of similar diseases in maternal relatives. Furthermore, we obtained blood samples from 20 consecutive patients with hypertrophic cardiomyopathy. To be included as a control in group 1 it was required that the subjects and their mothers should be free of diabetes mellitus, sensorineural hearing impairment, and neurological ailments and that their mothers should have been born in central or northern Finland. After obtaining this information, the samples were anonymised.
Group 2 included 497 patients with AD, non-Alzheimer dementia, or PD. The inclusion criteria for patients with AD were those of NINCDS-ADRDA. 12 All the patients with PD satisfied the PD Brain Bank (London) criteria for idiopathic PD, that is, akinetic rigid syndrome with asymmetrical onset, resting tremor, and a good response to L-dopa. 13 The non-Alzheimer dementia group included patients with Parkinson plus syndrome or frontotemporal dementia.
14 The control samples in group 2 were from 107 elderly subjects recruited from the same population as the patients with AD and assessed for cognitive performance to exclude dementia. The research protocol was approved by the local Ethics Committees and the Finnish Red Cross. Permission for the chart review was obtained from the Finnish Ministry of Social AVairs and Health.
Blood samples were obtained from the patients after written informed consent. Total DNA was isolated from the blood cells using a QIAamp Blood Kit (Qiagen, Hilden, Germany), and restriction fragment length polymorphisms (RFLPs) were used to identify the most informative polymorphic sites. The subsequent definitions of the various mtDNA haplogroups conformed to the published criteria. 15 The tRNA Gln 4336A>G mutation was detected by restriction fragment analysis using NlaIII. The mtDNA region was amplified in PCR using a forward primer spanning nucleotides 3951 to 3970 16 and a reverse primer spanning nucleotides 4508 to 4489. The template DNA was amplified in a total volume of 50 µl by PCR in 30 cycles of denaturation at 94°C for one minute, annealing at 55°C for one minute, and extension at 72°C for one minute, with a final extension at 72°C for 10 minutes. The amplified DNA fragment (557 bp) was then digested overnight at 37°C with 10 U of NlaIII (New England Biolabs, Beverly, MA, USA) and electrophoresed through a 1.5% agarose gel. The PCR fragment remained undigested when the wild type nucleotide was present, but was cleaved into fragments of 388 and 169 bp when the 4336A>G mutation was present. The PCR fragment also encompassed a nucleotide variant 4216T>C, which is a common variant in haplogroups T and J 15 that creates a novel NlaIII site gain. The PCR fragment was cleaved into fragments of 289 and 268 bp when 4216T>C was present.
Conformation sensitive gel electrophoresis (CSGE) was carried out as described previously. 17 In short, 63 pairs of primers were designed for amplification of the mtDNA coding region (nt 574-16023). The template DNA was amplified in a total volume of 50 µl by PCR in 30 cycles of denaturation at 94°C for one minute, annealing at a primer specific temperature for one minute, and extension at 72°C for one minute, with a final extension at 72°C for 10 minutes. The quality of the amplified fragment was estimated visually on a 1.5% agarose gel, and a suitable amount of the PCR product, usually 3-10 µl, was then taken for heteroduplex formation. Each amplified fragment of mtDNA from the patients with 4336A>G was mixed with the corresponding fragment amplified on two control templates, respectively, the complete sequences of which were known. 17 The amplified fragments were denatured at 95°C for five minutes and the heteroduplexes were subsequently allowed to anneal at 68°C for 30 minutes.
The polyacrylamide gel was prepared as described previously, 17 pre-electrophoresed for 30 minutes, and the heteroduplex samples were electrophoresed through it at a constant voltage of 400 V overnight at room temperature. After electrophoresis, the gel was stained on a glass plate in 150 µg/l of ethidium bromide for five minutes followed by destaining in water. It was then transferred to an UV transluminator and photographed (Grab-IT Annotating Grabber 2.04.7, UVP Inc, Upland, CA).
PCR fragments within the coding region and with diVerential mobility in CSGE, together with the hypervariable segment I (HVS I) in the D loop of the patients and the population samples, were analysed by automated sequencing (ABI PRISM TM 377 Sequencer using Dye Terminator Cycle Sequencing Ready Kit, Perkin Elmer, Foster City, CA) after treatment with exonuclease I and shrimp alkaline phosphatase. 18 The primers used for sequencing the coding region were the same as those used in the amplification reactions for CSGE. The HVS I was amplified in a fragment spanning nts 15714 and 16555 and the sequence was determined between nts 16024 and 16400.
Results
Eight middle aged patients in group 1 (1.4%) with various clinical phenotypes and three of the group 1 controls (0.63%) carried the 4336A>G mutation (table 1), this being most frequent among the patients with sensorineural hearing impairment and migraine. In addition, the mutation was found in occasional patients with diabetes mellitus or hypertrophic cardiomyopathy. The odds ratios (OR) were higher than unity for many patient groups (table 1), but calculation of the 95% confidence intervals suggested a significant increase only in the case of migraine and sensorineural hearing loss.
Five patients in group 2 (1.0%) but none of the controls harboured 4336A>G. The mutation was found in three patients with Alzheimer's disease, one with non-Alzheimer dementia, and one with Parkinson's disease, but it was not found among the 107 cognitively normal elderly subjects.
The mtDNAs harbouring the 4336A>G mutation belonged to haplogroup H. Furthermore, we determined the entire sequence in the mtDNA coding region and HVS I in 10 out of the 13 patients with 4336A>G, the three AD patients being excluded because of an insuYcient amount of sample. The data were used to construct a phylogenetic network 19 ( fig 1) . There were eight mtDNA substitutions in the coding sequence that diVered from the revised Cambridge reference sequence. 20 Three of the variants were silent mutations and three were common polymorphisms (709G>A in 12S rRNA, a 9 bp deletion in a non-coding region T4336C  T14766C  T16304C   A263G  A750G  A1438G  del C 3106  G3423T  A4769G  G4985A  A8860G   G9559C  T11335C  G13702C  G14199T  G14272C  G14365C  G14368C  A15326G   Table 2 Evolutionary conservation of amino acids in ATPase subunit 6. The transition T to C at nt 9128 in patient 10 replaces the moderately conserved hydrophobic isoleucine (*) with hydrophilic threonine
between nts 8272 and 8280, and 14766T>C in the cytochrome b gene). The remaining two substitutions, 4336A>G and 9128T>C, were considered rare variants. The 9128T>C mutation, found in a patient with frontal lobe dementia, leads to an isoleucine to threonine amino acid replacement in ATPase subunit 6, and this amino acid was found to be moderately conserved in evolution according to information from the Entrez-Protein data bank (http://www.ncbi.nlm.nih.gov). This site is almost invariably occupied by a hydrophobic aliphatic amino acid, the only exception being in Gorilla gorilla, where it contains methionine (table 2) . A 5 bp insertion between nts 956 and 965 in the 12S rRNA gene and 3397A>G in the ND1 gene have been reported previously in patients with AD and 4336A>G. 5 Neither of these variants were found in our 10 patients harbouring 4336A>G.
The 13 patients harbouring 4336A>G were not clinically distinct, although six of them presented with more than one phenotype (table  3) . Syndromic features were seen only in patient 4, who presented with hypertrophic cardiomyopathy, epilepsy, non-migrainous headaches, psychiatric symptoms, and cognitive decline. Age at the onset of the leading phenotype among the 13 patients did not diVer from that among the patients without 4336A>G, but, interestingly, the age at onset for the patient with Parkinson's disease (patient 9) was 40 years.
Discussion
The 4336A>G mutation has previously been found at an increased frequency among patients with neuropathologically defined AD, [5] [6] [7] but other studies have failed to detect any diVerence in the frequency of this mutation between AD patients and controls 21 or have shown a decreased frequency. 22 23 We found 4336A>G in three out of 175 patients with AD (1.7%), whereas none of the 107 cognitively normal elderly subjects harboured the mutation. A total of 748 patients with AD have been screened for 4336A>G in the six previous studies and the present study combined, and 17 (2.3%, 95% confidence interval 1.20-3.34%) have been found to harbour the mutation, suggesting that the frequency of 4336A>G may be increased among patients with AD. Our results, moreover, show a similar finding among middle aged patients with phenotypes commonly associated with mitochondrial diseases, as patients with migraine harboured 4336A>G at a frequency of 4.8% and patients with matrilineal sensorineural hearing impairment at a frequency of 3.6%.
The frequency of 4336A>G among the controls, comprising middle aged Finnish blood donors, was 0.63%, which is similar to that reported for controls previously, 5 6 although this mutation has been found at frequencies as high as 2.0 to 3.8% in control samples from British, 23 24 German, 25 French-Canadian, 21 and US populations. 22 The variation in frequency found in the three studies with more than 200 subjects is 0.34-0.71% 5 6 (present study), whereas that in the six studies with fewer than 200 subjects 7 21-25 is much larger (0-3.8%), suggesting that a sampling error may be involved, although true diVerences between the populations cannot be ruled out. In the eight previous studies, 5-7 21-25 a total of 2751 subjects had been examined for 4336A>G, yielding 27 cases of the mutation (proportion of carriers 0.98%, 95% confidence interval 0.79-1.17%). The frequency of 4336A>G in the Finnish population may thus be lower than that in other white populations. Interestingly, we have previously found that a haplotype harbouring 5656A>G within haplogroup U is more than 30-fold more common among the Finns than elsewhere in Europe. 26 The mtDNAs bearing 4336A>G belonged to haplogroup H, which is the most common European specific haplogroup, being found at an average frequency of 50%. 27 Since haplogroup H has been found less than three times among 1175 non-whites, 15 the lack of the 4336A>G mutation in Japanese patients 28 is not surprising. Sequence analysis of our patients and controls indicated that 4336A>G occurs together with 14766T>C and 16304T>C, suggesting that it occupies a specific branch in the phylogenetic network. Nine patients and 15 controls had also been characterised previously by the 16304T>C variant 6 22 or the corresponding RsaI site loss or AvaII site gain at nt 16303, 5 suggesting that they also belong to the same branch. We determined the mtDNA sequence of the coding region and the HVS I segment in 13 samples with 4336A>G (10 patients and three controls), but although the samples belonged to 10 diVerent haplotypes, the polymorphisms characterising the haplotypes were more peripheral in the network in every case, suggesting that 4336A>G had arisen earlier. Interestingly, one control 22 with 4336A>G had been found to harbour not 16304T>C but 16356T>C, a variant which characterises haplogroup U4 27 but which has also been found in a sample belonging to haplogroup H harbouring 16189T>C and 16223C>T. 29 Comparison of the latter haplotype with those in the 4336A>G network based on our samples nevertheless suggests that 4336A>G has indeed arisen at least twice in human evolution. It has been suggested that 4336A>G may not contribute to the pathogenesis of AD in itself but may serve as a marker of a haplotype harbouring a pathogenic mutation. Our results showed, however, that the mtDNAs with 4336A>G harboured nine diVerent substitutions, none of which was held in common. The additional substitutions included three polymorphisms in the HVS I, four in the protein coding sequence, one in the 12S rRNA gene, and one in a non-coding segment between the COX II gene and the tRNA Lys gene. Only 9128T>C in the ATPase6 gene was considered potentially pathogenic, as it was not found among 480 controls and sequence comparison showed that it changed a moderately conserved isoleucine to threonine. This substitution was found in a patient with frontotemporal dementia (patient 10), the clinical features of which did not conform to the clinical criteria for AD.
The patients with sensorineural hearing impairment or migraine and with 4336A>G were not clinically distinct. Interestingly, one of those with AD (patient 12) had insulin dependent diabetes mellitus and another (patient 13) had sensorineural hearing impairment. Both of these disorders are common phenotypes of mitochondrial disorders. 30 Patient 10 was diagnosed with clinically typical frontotemporal dementia at the age of 66 years. Apathy and reduced speech were the main symptoms at onset and single photon emission computed tomography with 99m
Tchexamethylpropyleneamine oxime as the tracer isotope showed left temporoparietal hypoperfusion. Patient 9, with PD and harbouring 4336A>G, was clinically unremarkable except for the early onset.
Previous studies have implied a role for 4336A>G in late onset neurodegenerative diseases. We found that the frequency of 4336A>G in the tRNA Gln gene was significantly higher in patients with matrilineal sensorineural hearing impairment or migraine than in the controls, suggesting that the mutation may be involved in diseases already manifest in middle life. 4336A>G was the only mtDNA variant that was common to the patients, and it could therefore have a causal role in sensorineural hearing impairment or migraine and is not simply a marker linked to another, more significant mtDNA mutation.
The expert technical assistance of Ms Anja Heikkinen is acknowledged. This work was supported in part by grants from the Medical Research Council of the Academy of Finland, the Sigrid Juselius Foundation, the Finnish Medical Foundation, the Neurology Foundation, and the Maire Taponen Foundation, and by EVO grants from the Kuopio University Hospital.
Split hand/split foot malformation associated with sensorineural deafness, inner and middle ear malformation, hypodontia, congenital vertical talus, and deletion of eight microsatellite markers in 7q21.1-q21.3
Edda Haberlandt, Judith LöZer, Almut Hirst-Stadlmann, Bernd Stöckl, Werner Judmaier, Helmut Fischer, Peter Heinz-Erian, Thomas Müller, Gerd Utermann, Richard J H Smith, Andreas R Janecke EDITOR-The split hand/split foot malformation (SHFM, MIM 183600) is a central reduction defect of the hands and feet and occurs both as an isolated malformation and as part of several syndromes including the EEC syndrome (MIM 129900). We report on a 2 year old boy with SHFM associated with features of ectodermal hypoplasia, a submucous cleft palate, congenital vertical talus, malformations of the middle ear, profound sensorineural hearing loss resulting from Mondini dysplasia, and a de novo deletion of the paternal chromosome 7q21.1-q21.3. This patient with syndromic SHFM represents a case of atypical EEC syndrome, but also displays abnormalities previously not associated with SHFM or EEC syndrome.
The classical features of the autosomal dominant inherited EEC syndrome are ectrodactyly, ectodermal dysplasia, and clefting of the lip/palate. In most patients, there are additional anomalies typically aVecting the urogenital and lacrimal systems. 1 2 Some patients also have dysmorphic facies, a tendency to infectious disease, endocrine disorders, and mental retardation. This phenotypic variability has become increasingly apparent over the last 15 years 3 4 and numerous related and overlapping syndromes have been delineated by many investigators. 5 In an attempt to clarify classification, major and minor criteria for the diagnosis of EEC syndrome have been elaborated. families. 6 At least 15 patients have been reported to have cytogenetic abnormalities of chromosome 7q21.2-7q22.1, including nine patients with interstitial deletions. [7] [8] [9] In addition, mutations in the gene encoding the transactivation factor p63 on chromosome 3q27 have been identified in familial and sporadic cases of EEC syndrome. 10 A third locus was mapped to chromosome 19q, 11 further delineating the genetic heterogeneity of this syndrome. The reason for the phenotypic heterogeneity in EEC syndrome patients with 7q abnormalities is unclear but may relate to the size of the deletion.
Case report
Our patient is the fifth child of healthy, consanguineous, fourth cousin, Austrian parents. The father and the mother were 41 and 36 years, respectively, at the time of his birth. His four sibs are healthy. He was born after an uneventful pregnancy in the 41st week of gestation and weighed 2840 g (10th centile), was 48 cm long (10th centile), and had a head circumference of 31.5 cm (10th centile). Ectrodactyly of the right foot was noted and transient evoked otoacoustic emission screening indicated hearing impairment. Further examinations were at first declined by the mother. At 15 months of age, he was referred to the hospital because of failure to thrive (weight 7200 g, below the 3rd centile; length 70 cm, below the 3rd centile; head circumference 43 cm, below the 3rd centile). Physical examination showed arched eyebrows, a small triangular nose with a depressed nasal bridge, and ears with overfolded helices and attached earlobes (fig 1) . He also had hypertelorism, a large biparietal diameter, hypopigmented retina, micrognathia, a submucous cleft palate, carious primary teeth and hypodontia, sparse, light hair, pale skin, cryptorchidism, and bilateral severe congenital vertical talus, in addition to the previously noted ectrodactyly of the right foot (fig 2) . CT and MRI scans showed Mondini dysplasia of the inner ear ( fig 3) and cochlear implanting showed fixation of the ossicular chain. Audiometric examinations were consistent with these findings and showed conductive and profound sensorineural hearing loss. Laboratory investigations showed partial deficiency of growth hormone secretion. Mental and psychomotor developmental delay was noted.
Figure 3 Inner ear of the patient. A 3D reconstruction of a coronal MRI scan shows Mondini type malformation on both sides. (A) Right ear: overall dilated and plump structures of the inner ear. asc denotes the anterior semicircular canal, va the vestibular aqueduct with saccule and utricle, and co the cochlea showing a reduced number of coils. (B) Left ear: a large endolymphatic sac is shown (es). (C) Schema
On GTG banding, we observed an interstitial deletion of chromosome 7 confined to the interval q21.1-q21.3 ( fig 4A) ; parental karyotypes were normal. To delineate this deletion further, we used 21 chromosome 7q microsatellite markers to reconstruct parental and patient haplotypes and found that for the eight markers flanked by D7S2443 and D7S2480, the patient had a deletion of the paternal allele ( fig 4B) . Two markers within the interval (D7S2410 and D7S527) were uninformative, as were two flanking markers (D7S524 and D7S1796). These data define a deletion of 8.9 to 17 cM , which includes the critical interval of <1 Mb on 7q21.3 previously associated with either SHFM or EEC syndrome. 7 9 13 Discussion Extensive investigations have not been able to support any of several hypotheses to connect the chromosomal aberrations with the occurrence and varying characteristics of syndromic SHFM . 13 15 Given the rare occurrence of cytogenetic abnormalities in persons with syndromic and non-syndromic SHFM, the fact that the deletion we report includes the critical region previously described in patients with SHFM emphasises the importance of this chromosome 7 interval in the pathogenesis of SHFM/syndromic SHFM. Furthermore, we believe that the range of phenotypic findings in SHFM patients with aberrations of chromosome 7q favours a contiguous gene syndrome as the underlying cause.
In our patient, the inner ear malformation (fig 3) was recognised as Mondini dysplasia, an 12 and Crackower et al. 13 14 The arrow indicates the position of the gene mutated in Pendred syndrome. D7S663  D7S2455  D7S634  D7S2443  D7S524  D7S492  D7S2410  D7S657  D7S2482  D7S527  D7S1812  D7S821  D7S2539  D7S479  D7S491  D7S1796  D7S2480  D7S647  D7S501  D7S692   M  F   SL  M  F  SL   3 2  3 2  3 1  1 2  2 2  2 1  2 2  1 1  1 1  1 3  2 1  3 3  2 2  3 3  1 2  3 3  2 3  1 2  2 2  1 1  3 2   D7S2506  D7S663  D7S2455  D7S634  D7S2443  D7S524  D7S492  D7S2410  D7S657  D7S2482  D7S527  D7S1812  D7S821  D7S2539  D7S479  D7S491  D7S1796  D7S2480  D7S647  D7S501  D7S692   1 4  4 1  2 4  2 3  1 3  2 3  1 2  1 1  3 2  2 3  3 2  2 1  1 3  2 1  3 association that has not previously been reported with either SHFM or a chromosome 7 aberration. Mondini dysplasia is characterised by bony and membranous anomalies of the inner ear exhibiting a wide range of morphological and functional abnormalities. Typically, the cochlea is flat, the cochleal duct is short, the auditory and vestibular sense organs and nerves are immature, the vestibule is large, the semicircular canals are wide, small, or missing, and the endolymphatic sac is dilated. The anomaly can be unilateral or bilateral and occurs in isolation or in association with anomalies in other organs. 16 Familial examples of Mondini dysplasia generally represent examples of Pendred syndrome, an autosomal recessive disorder in which congenital sensorineural hearing impairment and goitre cosegregate.
Because Pendred syndrome is caused by mutations in PDS, a gene that maps to chromosome 7q31, the simultaneous occurrence of atypical EEC syndrome and Pendred syndrome in our patient seemed an attractive possibility to explain the rare combination of physical findings. Although molecular analysis in our patient appears to place the distal breakpoint of the deletion about 9 cM centromeric to PDS, we cannot exclude a more complex chromosomal rearrangement. Assuming that the paternal copy of PDS could have been deleted, we completed a mutation screen for maternally inherited PDS allele variants. We were unable to identify any mutations by SSCP and direct sequencing as described previously 17 and therefore could not establish a causal connection between the observed Mondini dysplasia and the chromosomal aberration. We also excluded an independent cause of the sensorineural hearing impairment, by sequencing the coding region and exon 1 of GJB2. 18 Mutations in this gene are the most common cause of autosomal recessive non-syndromic deafness.
The simultaneous occurrence of an inner ear malformation and SHFM has rarely been reported. Berndorfer 19 noted absence of pinnae and lack of inner ears in one patient. Autosomal dominant ectrodactyly and deafness in a father and son were reported by Tolmie et al. 20 Both patients had CT verified cochlear abnormalities, which may have been consistent with Mondini dysplasia. There was no mention of any chromosomal anomaly. Moreover, sensorineural hearing impairment has rarely been reported in syndromic SHFM. [21] [22] [23] [24] [25] [26] In two of these cases, however, an apparently balanced translocation involving chromosome 7q was found to cosegregate with the disease. 25 26 Conductive hearing loss is observed in 14-44% of cases of EEC syndrome, most commonly reflecting Eustachian tube dysfunction in association with the palatal clefting, 3 4 although ossicular malformations have been described. 27 Of 10 patients with ectrodactyly in association with a deletion of 7q21-q22, microcephaly and general growth impairment have been reported in eight cases (80% 7 9 ) compared to only 2% and 1%, respectively, in a survey of 230 patients with EEC syndrome. 4 While adenohypophyseal dysfunction in two sets of sibs has been reported in EEC syndrome, 28 29 partial growth hormone deficiency was identified in our patient as the aetiology of the growth retardation. However, growth retardation and microcephaly might also delineate a subtype of the EEC syndrome related to chromosomal aberrations involving chromosome 7q21-q22. We accordingly suggest initiating chromosomal and molecular investigations of this chromosomal region when growth retardation and microcephaly is present in patients with SHFM. Short stature, as well as low birth weight, abnormal skull shape, and ear malformations were common findings among patients with proximal/intermediate deletions or rearrangements of chromosome 7q, with and without SHFM. 8 We believe that a specific pattern of facial anomalies characterises patients with aberrations of chromosome 7q21-q22. The facial phenotype consists of arched eyebrows, a small, triangular shaped nose with a depressed nasal bridge, abnormal ears with overfolded helices and attached earlobes, a large biparietal diameter, hypertelorism, and micrognathia. It was present in our patient and in at least six published case reports. 9 30-34 The split foot malformation in our patient was right sided, as has been mostly observed in cases of unilateral involvement of either the upper or lower limbs. 26 The presence of bilateral congenital vertical talus could not be explained by aplasia of the anterior calcaneus with loss of talar support or by a spinal defect, though the split foot malformation complicates the anomaly of the talus. Bilateral congenital vertical talus is an otherwise rare disorder, and to our knowledge has not been reported in the EEC syndrome or in related conditions.
Our report suggests that patients with syndromic SHFM should be examined for the findings we describe, and that the molecular analysis should include karyotyping and complementary studies to establish whether the critical interval of <1 Mb on chromosome 7q21.1-q21.3 is deleted.
We are grateful to the family that made this research possible. This study was supported in part by research grant number 1RO1 DC02842 from the National Institute on Deafness and Other Communication Disorders, National Institutes of Health (RJHS) and by grant No P12792-GEN from the Austrian Science Fund (GU).
A missense mutation in the SEDL gene results in delayed onset of X linked spondyloepiphyseal dysplasia in a large pedigree E Grunebaum, E Arpaia, J J MacKenzie, J Fitzpatrick, P N Ray, C M Roifman EDITOR-Spondyloepiphyseal dysplasia (SED) is a rare osteochondroplasia, characterised by disproportionate short stature with a short neck and trunk and barrel chest. The pelvis tends to be narrow and deep, the femoral neck short, and the femoral head flattened. Mild to moderate epiphyseal dysplasia of the large joints may also be seen. The latter may lead to premature secondary osteoarthritis with significant morbidity.
1 SED may occur sporadically; however, in many cases the family history indicates an inherited condition. In some of these pedigrees, the inheritance pattern seems autosomal dominant, while in others it is consistent with autosomal recessive or X linked recessive. 2 Recently, mutations in the gene designated SEDL, located on Xp22, were identified as the cause of X linked spondyloephiphyseal dysplasia tarda in three families. 3 We have previously described a large kindred of British descent spanning four generations aVected by SED. 1 Briefly, 14 males between the ages of 10 and 77 years were aVected, with early adolescence development of progressive decline in growth rate accompanied by short stature, short trunk, and barrel chest. Although some of them had to limit their activities because of hip or back limitation of movement or pain, many continued with normal activity and were able to perform in the work place without impairment of function. There was no indication of other abnormalities previously reported in association with SED, such as mental retardation, 2 immune abnormalities and retinopathy, 4 cardiac dysfunction, 5 or hypogonadotrophic hypogonadism. 6 The female carriers in this pedigree had normal height. Although some of the females suVered from occasional mild back or hip pain, it did not aVect their daily activity, nor was there objective radiological evidence of spinal or joint involvement compatible with SED. In this large pedigree, linkage analysis performed using RFLP and microsatellite markers showed association between the Xp22 markers DXS1224, DXS16, DXS987, and DXS207 with SED. 1 We now have assessed this pedigree for the presence of mutations in the SEDL gene.
Material and methods
Genomic DNA was extracted from peripheral blood leucocytes of 13 family members and 50 normal blood donors as previously described. 1 5 Four X specific primer pairs, which flanked each of the four coding exons and a significant portion of the intron-exon junctions of SEDL, were used for PCR amplification (table 1) . PCR reactions were performed with Elongase (Gibco-BRL) under the following conditions: 94°C for one minute followed by 35 cycles of 94°C for 30 seconds, 60°C for 30 seconds, and 68°C for 60 seconds. The PCR products were sequenced using Thermosequenase kit (Amersham) as specified by the manufacturer.
Results
Genomic DNA sequencing indicated that in all six aVected males with SED a T to C substitution at nucleotide 248 in exon 5 was present ( fig 1A) . Sequencing in the forward and reverse direction of exon 5 PCR product, which was subcloned into pUC-19, confirmed the presence of the mutation. Five obligate female carriers were heterozygous for both the C and T at this position (fig 1B) , which was not detected in the two unaVected male family members, nor was it found in 50 normal blood donors.
The mutation is predicted to cause a substitution of phenylalanine (F) by serine (S) at amino acid 83. The phenylalanine at this position is highly conserved, as it is identical in the SEDL protein homologue found in mouse, yeast, C elegans, and D melanogaster. 3 Several programs used to predict secondary protein structure, GOR IV, 7 HNNC, 8 and Predator, 9 indicated that the mutation would significantly alter the protein structure and introduce an additional alpha helix (fig 2) . The cosegregation over three generations of a mutation in the gene for SEDL and spondyloepiphyseal dysplasia further establishes the association of the genetic defect and SED. This change is found in all aVected subjects examined and five obligate carriers are heterozygous. SEDL sequence was completely normal in two male family members who had no clinical evidence of SED, as well as in 50 unrelated normal donors.
Discussion
Contrary to previously reported mutations, which result in truncated message and probably in complete loss of SEDL function, 3 the impact of the T→C missense mutation described here may be diVerent. The SEDL gene is relatively short and the substitution of the bulky phenylalanine side chain for a highly hydrophilic side chain of serine may cause a structural or functional change in the protein.
The function of SEDL and its role in bone metabolism remains unknown; however, several methods to predict the structure and function of proteins have suggested a significant change. A phenotype/genotype correlation is diYcult to determine; however, an amino acid change that does not alter the rest of the protein may not be as detrimental to the Contrary to other pedigrees with X linked SED, in which females heterozygous for the gene defect suVered from subtle skeletal abnormalities and arthritis by middle age, 10 11 the female carriers in the family described here had no objective evidence of SED. This may reflect the subtle impact of the C→T mutation on SEDL protein function.
In the family described here we were able to confirm that a male of uncertain status (IV.8) had no mutation in SED. Thus, the ability clearly to diagnose SED by molecular methods in children with joint or spine abnormalities is of extreme importance, as it may allow appropriate and early intervention.
Molecular characterisation of a new case of microphthalmia with linear skin defects (MLS)
Hülya Kayserili, Timothy C Cox, Liza L Cox, Seher Basaran, Gülleyla Kiliç, Andrea Ballabio, Memnune Yüksel-Apak EDITOR-Microphthalmia with linear skin defects (MLS) is a clinically complex and highly variable phenotype in XX subjects and has been considered to be at least partially determined by three features: the pattern of X chromosome inactivation; the extent of the Xp22.3 segmental monosomy; and the nature of the chromosomal anomaly (deletion or translocation).The recurring features of microphthalmia with linear skin defects, generally restricted to the face and neck in all the early reported cases, led to its designation as the MLS syndrome. The consistent association of these two manifestations with Xp22.3 segmental monosomy suggests that MLS is a contiguous gene syndrome. 1 2 However, the phenotype may be complicated by additional abnormalities which include sclerocornea, chorioretinal abnormalities, agenesis of the corpus callosum, hydrocephalus, infantile seizures, mental retardation, and congenital heart defects. To date, around two dozen cases of MLS syndrome (including our case) have been published and in approximately half (including our case), the Xp22.3 disruption has resulted from a terminal deletion. [3] [4] [5] [6] [7] [8] [9] [10] In the remaining cases, Xp22.3 segmental monosomy is a consequence of X;Y 8 11-13 or X;autosome translocations. [14] [15] [16] [17] [18] In all cases, there is monosomy for over 10 megabase pairs and comparison with patients harbouring smaller deletions has defined a ∼570 kb interval that must contain the gene(s) giving rise to the diagnostic clinical features of the disorder, including microphthalmia, sclerocornea, and linear skin defects. Subsequent and ongoing investigations have led to the identification and characterisation of three genes from this minimal region as well as the precise mapping of a number of expressed sequence tags (ESTs). However, it is still currently unknown which gene(s) are responsible for this unique combination of features. Wapenaar et al 19 20 used cell lines from 10 MLS cases with deletions and translocations involving the Xp22 region to investigate the minimal region of monosomy leading to all the diagnostic features of the syndrome.
The entire region spanning the defining breakpoints has been cloned into overlapping cosmids, establishing the critical region to be approximately 570 kb in size and located just distal to the AMG locus. [19] [20] [21] Recent eVorts directed at identifying the causative gene(s) for MLS have resulted in the mapping and preliminary characterisation of three genes from the critical interval: the X linked Opitz syndrome gene, MID1, 22 23 a gene encoding a holocytochrome c synthase (HCSS), 24 and a gene encoding a GTPase activating protein, ARHGAP6 (this paper). 25 None of these genes has yet been implicated in the diagnostic features of the MLS phenotype.
Case report
Here we present a female patient with MLS, who had unusual, red, reticulolinear, nonvesicular, erythematous skin lesions on her face and neck and bilateral microphthalmia at birth. Relative microcephaly and linear streaks of erythematous skin on the face starting medial to the inner canthi (3-4 mm in width) and continuing down along the side of the nose and onto the cheeks were noted. The streak (medial to the nasolabial sulcus) on the right continued down the jaw line. The skin lesions on the neck were less linear and more reticular in pattern.
The skin on the remainder of the body was normal (fig 1) . Apart from small ears, a high arched palate, and hypoplastic genitalia, other systems were normal. A CT scan showed small bulbus oculi (5 mm in diameter) bilaterally, 
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intact extraocular muscles and optic nerves, and agenesis of the corpus callosum. On re-evaluation at 6 months of age microcephaly (OFC of 38 cm) was prominent with a normal height and weight. The skin lesions were milder in appearance than at the previous examination but became more prominent with crying ( fig  2) . Her developmental milestones were moderately delayed. High resolution chromosome studies showed a 46,X,del(X) (p22.3→pter) karyotype (fig 3) . Both parental karyotypes were normal.
To investigate the extent of the deletion further, we typed 15 polymorphic markers that map to Xp22 on DNA prepared from the proband and her parents. In fact, most of these markers were known to map within or immediately around the MLS critical region. 21 The results clearly and precisely showed the localisation of the patient's breakpoint ( fig 4A) . All informative microsatellites that were tested from Xpter to DXS9983 (within the MLS critical region) showed absence of the paternally derived X chromosome in the patient. DXS9993, and all markers further centromeric to it, clearly showed the presence of both paternal and maternal alleles in the proband ( fig 4A) . Unfortunately, other recently developed markers (DXS9982, DXS9984, and DXS9986) located between DXS9983 and DXS9993 21 were uninformative and thus the position of the breakpoint could not be further refined. Verification of the microsatellite findings was, however, obtained by both fluorescence in situ hybridisation analysis of metaphase chromosomes and quantitative Southern blot analysis of DNA from the parents and the proband using three diVerent cosmids and subcloned cosmid fragments, respectively, as probes (data not shown). Trapped exons and selected cDNA fragments were used as complex probes on cDNA libraries derived from various tissues. Multiple cDNA clones were isolated from an Adult Retina library that each derived from the same gene. Sequencing and compilation of these cDNAs indicated that the gene probably encodes a GTPase activating protein (data not shown). The gene was subsequently reported by others as the ARHGAP6 gene. 25 We have determined the relative position and exonic organisation of the ARHGAP6 and AMG genes, which are known to map in the vicinity of the position of the breakpoint in our patient. These analyses showed the ARHGAP6 gene to be composed of 16 exons which are transcribed in the centromere to telomere direction ( fig 4B, fig 5) . These new data have led to the identification of an additional 5' untranslated exon approximately 160 kb further centromeric to the previously designated first exon, extending the ARHGAP6 gene size to approximately 350 kb. This finding thus places the small AMG gene within the first intron of ARHGAP6 and transcribed in the opposite direction. Strikingly, our cDNA data and genomic sequence analysis suggest that complex alternate splicing is occurring at both the 3' and 5' ends of the ARHGAP6 gene. Consequently, multiple protein isoforms are predicted to be encoded by this gene. Our microsatellite data therefore position the breakpoint in our patient between the AMG gene and exon 6 of the ARHGAP6 gene ( fig 4B) . Interestingly, the breakpoint in the patient (BA325) previously defining the proximal boundary of the MLS critical interval is located between AMG and exon 2 of ARHGAP6 (fig 5) . 26 
Discussion
The cytogenetic and molecular analysis of the present case have clearly identified one of the smallest reported Xp deletions in a patient who expresses the full diagnostic phenotype of MLS. In fact, the breakpoint occurs within the same region as seen in a case (BA325) previously defining the proximal boundary of the critical interval. Our new data on the structure of genes around these breakpoints have indicated that both occur distal to the AMG gene (in intron 1 of ARHGAP6) and proximal to exon 6 (our case) or exon 2 (BA325) of the ARHGAP6 gene. Consequently, no functional product is expected to be produced from the severely truncated ARHGAP6 allele in these two patients. Our recent finding that the 5' end of MID1 is located approximately 120 kb proximal to the telomeric boundary of the MLS critical interval 23 implies that the minimal interval harbouring the gene(s) causing the diagnostic features of MLS must lie between the end of the MID1 gene and the breakpoint defined in this report, a region of only 450 kb. Notably, however, Prakash et al 26 have shown that even male mice harbouring a targeted disruption of the Arhgap6 gene show no detectable phenotypic or behavioural abnormalities. As approximately 190 kb of the 450 kb MLS region is taken up by the remainder of the ARHGAP6 gene, these findings suggest that the causative MLS gene(s) may reside within the 260 kb interval between the 5' end of MID1 and the 3' end of ARHGAP6. To date, only one full length gene (HCCS) has been described in this interval. 24 Targeting of this gene in mice is currently being performed to address its contribution to the MLS phenotype.
Both our patient and BA325 show considerable similarity in their clinical features over and above those necessary for diagnosis (that is, microphthalmia and linear skin defects). However, there are some diVerences. For example, case BA325 was documented as having sagittal clefting of the vertebrae, a small, "punched out" skull defect, and macular depigmented skin lesions on the trunk, 7 features not present in our case. As both cases have been shown to be terminal deletions of paternal origin, it follows that any diVerences in the clinical presentation of both cases is most likely attributable to diVerences in the pattern of X chromosome inactivation. However, diVerences in severity of particular features may also conceivably be the group.bmj.com on June 19, 2017 -Published by http://jmg.bmj.com/ Downloaded from result of diVerences in the genetic background, a phenomenon that has generally been ignored as a possible explanation in previous publications. In reviewing the clinical findings of the two dozen reported cases of MLS, it is likely that many of the frequently associated but non-diagnostic features observed in MLS females can be accounted for by monosomy of the X linked Opitz syndrome gene, MID1, which partially overlaps the MLS critical interval at its distal end (tables 1 and 2). Although Opitz syndrome is more severe in males, many females have been reported with some features of the disorder. In fact, clinical variability is also seen between aVected males of the same family, indicating that the variability in females (including MLS females) is likely to be determined by factors other than the status of X chromosome inactivation, such as genetic background or environmental influences. Among the clinical features shared by MLS females and cases of Opitz syndrome are facial dysmorphism, deformed ears, high arched palate, structural heart defects, mild craniosynostosis, anteriorly displaced or imperforate anus, and various genital defects. However, microphthalmia, sclerocornea, and linear skin defects have not been reported in Opitz syndrome. EDITOR-Cryptic telomeric rearrangements are a significant cause of idiopathic mental retardation. Knight et al 1 found 7.4% of these rearrangements in children with moderate to severe mental retardation. Clinical selection criteria for testing patients with subtelomeric chromosome specific probes are still not clear cut and the importance of other surveys to define this point has been stressed. 2 With this aim, we examined 200 patients with idiopathic mental retardation, either isolated or associated with dysmorphism and/or congenital anomalies, using FISH analysis with subtelomeric chromosome specific probes.
Material and methods
The sample was collected in four Italian Genetic Centres. Patients were selected on the basis of the following criteria: (1) the presence of mental retardation that was classified as mild, moderate, or severe according to DSM IV 3 ; (2) patients under 1 year of age, too young for psychological assessment, were selected for the presence of developmental delay; (3) exclusion of pre-or perinatal distress through an accurate evaluation of the pre-, peri-, and postnatal patient history; and (4) exclusion of Mendelian syndromes and of genomic disorders 4 5 for which a specific diagnostic test is available.
The essential elements of evaluation also included family history, a complete physical and neurological examination of the patients with particular attention to the presence of mental retardation and multiple congenital anomalies, and assessment of the behavioural phenotype. Electroencephalograms, brain CT scan, and MRI were performed in specific situations.
Abnormal methylation and expansion at FRAXA and FRAXE 6 were excluded in 52 and 50 males and in 37 and 32 females, respectively.
Routine cytogenetic analysis at the 400-550 band level was performed in all the patients. In those patients in whom a cryptic subtelomeric rearrangement was identified by FISH, prometaphase chromosomes were also analysed to determine if the rearrangement could be detected in retrospect by cytogenetic analysis. Chromosome preparations from peripheral blood or from lymphoblastoid cell lines were used for FISH analysis. The Chromoprobe-T kit with telomere specific clones 7 was used according to the supplier's instructions (Cytocell, UK) with minor modifications. To establish the origin of each rearrangement, FISH and microsatellite analysis with subtelomeric probes were performed in the parents of the patients. FISH experiments with diVerent YACs from each rearranged chromosomal region were performed to define its size. (table 1) , 44 had mild mental retardation (IQ 50-70), 62 were moderately retarded (IQ 50-35), and 55 were severely retarded . A total of 39 patients had mental retardation not otherwise specified. Mental retardation was familial in 53 and sporadic in 147 subjects; it was isolated in 23 subjects, associated with dysmorphism and/or congenital anomalies in 160 subjects, and unknown in 17. We identified 13 rearrangements (table 2) . Seven rearrangements were de novo deletions. Six rearrangements were derivative chromosomes inherited by a balanced parent in the five cases where the parents were available. Twelve rearrangements were present in patients with moderate (7/62, 11.2%) or severe (5/55, 9%) mental retardation, whereas one rearrangement was found in a 3 month old patient, too young to assess the degree of his psychomotor retardation. No rearrangements were found among the 44 patients with mild mental retardation.
Results

Among our 200 patients
In all the 13 subjects with rearrangements, mental retardation was associated with dysmorphism and, excluding case 12, with at least one serious congenital anomaly (table 3) . Cases 1-6 have unbalanced translocations. In the two families (cases 1 and 2) in which we could examine other relatives, we found that the translocation was present in several members, both in a balanced and unbalanced state. In family 1, in which an X linked dominant trait had been suspected, 8 the two translocations' derivatives were present in subjects with diVerent phenotypes and diVerent degrees of mental retardation, whereas in family 2 only one derivative was identified. In this family, the proband's mother received amniocentesis at 19 weeks' gestation because of fetoplacental hydrops. The presence of two paternal uncles with severe mental retardation and multiple congenital anomalies but with a normal karyotype made counselling diYcult. After normal cytogenetic results the pregnancy continued. At birth the child showed congenital chylothorax, facial dysmorphism, and bone malformations prompting the counsellor to request chromosome specific telomere testing. The test was then extended to the mentally retarded uncles, who showed the same unbalanced translocation. Also in family 3, the mother received amniocentesis at 18 weeks' gestation after the detection of omphalocele. The cytogenetic results were normal and the pregnancy continued. A previous pregnancy had resulted in a child who died immediately after birth. At necropsy, an atrial septal defect and accessory spleen were recorded. Since accessory spleen has been reported in association with 9p duplication, 9 one could speculate that this child was also unbalanced for the maternal translocation, having the der(13) instead of the der(9) found in the proband. In family 4, a paternal cousin was referred with mental retardation. Cases 7-13 have deletions and all of them are de novo. The origin of the deletion was paternal in cases 7 and 11 and maternal in case 9.
We identified by FISH and PCR analysis the breakpoints in most of the rearrangements. The size of the rearrangements ranged from less than 2 cM to 31 cM (table 4) . Some of the rearrangements involving large chromosome regions have not been detected cytogenetically because the translocated region has the same size and overlapping banding pattern of the Number  44  62  55  39  200  Familial  15  15  12  11  53  Sporadic  29  47  43  28  147  Isolated  13  8  2  23  Associated  28  53  52  27  160  U n k n o w n  3  1  1  1 2  1 7 *Unspecified degree of mental retardation or children below testing age. original region. In case 5, when we reanalysed the chromosomes with high resolution banding to verify if the rearrangement could be detected in retrospect, we discovered that the abnormal chromosome 5 appeared to have a longer short arm. In the mother, the translocation was also evident at the 400-550 band level owing to the small size of the der(4). Three rearrangements (cases 1, 5, and 7) involve chromosomal regions whose monosomy is associated with specific syndromes. In case 1, the 9p deletion spans 27 cM. The main anomalies found in the patient at birth were omphalocele, trigonocephaly, and genitourinary abnormalities (right cryptorchidism with micropenis), all of them reported in 9p22 deletions. [10] [11] [12] [13] However, based on London Dysmorphology Database suggestions, 14 C syndrome (trigonocephaly, metopic synostosis, strabismus, cryptorchidism) was suspected. These data indicate that some cases diagnosed as C syndrome could have chromosome 9p microdeletion as already hypothesised. 15 We cannot, however, exclude that the trigonocephaly is the result of the 13q duplication since it has been reported in at least three patients with 13q22-qter duplication. [15] [16] [17] [18] In case 4, the 18 cM 5p deletion covers the region of the characteristic cat-like cry (which has not been reported by the mother) but not that of the distinct facial features associated with the cri du chat syndrome. 19 In case 7, the Albright-like phenotype associated with distal 2q deletion 20 was in fact present. The breakpoint of the deletion spans the polymorphic markers D2S2253 and D2S338, placing between KW and RA cases of AHO-like syndrome reported by Wilson et al. 20 We recently narrowed the AHOlike critical region to 10 cM in the subterminal distal 2q (from D2S338 to D2S2253). 21 In conclusion, we show that cryptic unbalanced translocations and deletions are the cause of mental retardation and phenotypic anomalies in 13 out of 200 subjects without a previous diagnosis. In five of the cases, the finding of a balanced translocation in one parent makes it possible to monitor future pregnancies for the presence/absence of chromosome anomaly. For the seven de novo deletion cases, although the risk of recurrence is low, prenatal diagnosis of future pregnancies can monitor for the presence/absence of the deletion in case of parental germinal mosaicism.
The finding that cases 2 and 3 were cytogenetically investigated prenatally after the finding of echographic abnormalities and a suspicion of chromosome anomalies suggests extending the telomere test to these situations.
Discussion
The results of our study largely overlap those obtained by Knight et al. 1 Putting together the two sets of data one can conclude that 6.5-7.4% of the children with moderate/severe mental retardation have a cryptic telomeric rearrangement, whereas the probability of finding these anomalies among subjects with mild mental retardation is less than 0.4% (1 out 182 children in the English sample, 0 out 44 in the Italian one). In both studies half of the rearrangements are de novo deletions and half are unbalanced translocations inherited in most of the cases. In six out of the 15 families with cryptic translocations, both subjects with one derivative chromosome and subjects with the other one were present. In families with more members aVected by mental retardation, diVerences in the phenotypes associated with the two derivatives should help the clinician to encourage diagnostic laboratories to search for a chromosome anomaly. Knight et al 1 concluded that abnormalities that include the ends of chromosomes are the commonest cause of mental retardation in children with undiagnosed moderate to severe mental retardation. In fact, in our patients, subtelomeric rearrangements were always associated not only with moderate or severe mental retardation but also with dysmorphic features and congenital anomalies. Therefore, our conclusion is that once a well defined aetiological cause has been excluded, screening with subtelomeric probes should be applied in subjects with a "chromosomal phenotype". In fact, as stressed by Knight and Flint 2 in their review of subtelomeric probes and their use in clinical diagnosis, all telomere positive cases reported to date have had physical anomalies in addition to mental retardation. Recently, a whole genome microsatellite screening 22 has led to identification of two cases of interstitial aneusomy among 11 children (18%) with multiple congenital anomalies and mental retardation, normal for subtelomeric chromosome analysis. This indicates that among our 147 subjects with mental retardation associated with an abnormal phenotype and with a normal subtelomeric test, roughly 26 of them should have an interstitial rearrangement.
The detection of cryptic telomeric rearrangements through FISH with subtelomeric probes raised the question of whether most of these rearrangements could have been detectable by appropriate high resolution banding, 23 thus saving time and money. The same question had been raised when FISH was introduced to detect the 15q11-q13 deletion in Prader-Willi/ Angelman syndrome. The demonstration that both false negative and false positive results occur with high resolution banding [24] [25] [26] led to the conclusion that this technique is insuYcient for deletion detection. 27 The same Other anomalies included a horseshoe kidney and immature, low set ears. We now report a similar case and discuss possible aetiologies and the diVerential diagnosis.
Case report
This was the second pregnancy of a nonconsanguineous, healthy couple with an unremarkable family history; the mother was 26 years old. Ultrasonoraphic findings at 23 weeks' gestation were gross fetal ascites and enlarged echogenic lungs subsequently found to be the result of laryngeal atresia (fig 1) . There was a large facial cleft with an anterior encephalocele involving the left orbit (fig 1) . There were also flexion deformities at the wrists and hips suggesting bilateral radial and tibial aplasia, respectively (fig 1) . In view of the serious nature of the anomalies, the parents requested a termination of the pregnancy. Asystole was induced by intracardiac injection of potassium chloride and labour was induced. Analysis of fetal blood showed a normal karyotype (46,XX).
The fetus weighed 615 g and was hydropic (fig 1) . A detailed necropsy confirmed the prenatal findings. There was an anterior encephalocele herniating through a very large bony defect involving both frontal bones and two thirds of the parietal bones. A cartilaginous plug occluded the larynx. There was bilateral radial aplasia with a short right humerus, with three metacarpals, but only two sets of phalanges, resulting in two finger hands on both sides. There was bilateral tibial aplasia and the feet had five metatarsals on the right and four on the left. Five phalanges were present on the right but only two on the left. There was syndactyly of all four toes on the right and the first two on the left. Additional findings included short palpebral fissures and an enlarged pancreas with an increased number of islet cells. Gross examination of the brain showed an unlayered cortex suggesting agyria. However, this could not be confirmed as poor tissue preservation precluded accurate interpretation of the histological brain architecture.
Discussion
The fetus had a spectrum of malformations in which three distinct developmental fields, the upper airway, the central nervous system, and the limbs, were aVected. Bilateral radial/tibial aplasia is a well defined malformation seen in many genetic disorders. 2 However, laryngeal atresia and an anterior encephalocele are both extremely rare anomalies.
Several possible diagnoses were considered in our case, Fraser syndrome, frontonasal dysplasia, and Mohr-Majewski syndrome (table  1) . However, in all cases there were significant diVerences making these diagnoses unlikely.
Another possible aetiology is amniotic band disruption which has been reported in both encephalocele and limb abnormalities. 3 However, this is very unlikely for several reasons. Neither ultrasound nor pathological examination showed evidence of abnormal amniotic band formation. In cases where bands are thought to be the cause of limb anomalies, the abnormality is usually one of transverse or amputation defects, 2 whereas in our case there were rudimentary limbs, with syndactyly and shortening.
In 1987, Machin et al 1 described a fetus with a similar range of anomalies, including laryngeal atresia, an asymmetrical left midparietal encephalocele, and limb anomalies (see table  1 ). The features described in this case are very similar to those we describe, although limb abnormalities were less severe and no renal abnormality was found in our case, whereas in the case described by Machin et al 1 there was a horseshoe kidney.
Laryngeal atresia is a very rare congenital malformation that is incompatible with life. In cases of complete obstruction, lung liquid accumulates within the lungs resulting in a clinical entity that has been termed congenital high airway obstruction syndrome (CHAOS). 4 Ultrasonographic features in aVected fetuses are characteristic and include bilateral, enlarged, echogenic fetal lungs together with dilated airways distal to the larynx, ascites with or without hydrops, and a small, compressed heart. Prenatal confirmation of laryngeal atresia is possible by direct visualisation of the obstructed larynx. 5 However, the major diVerential diagnosis is bilateral congenital cystic adenomatoid malformation type II or III, 
